Careers  |   Log In  |   Register  |   Welcome Center  |   Follow Us  Facebook  Twitter Google Plus

Latest in Resource Center: Prostate Cancer

By Ransdell Pierson (Reuters) – The anti-CTLA-4 antibody ipilimumab (Yervoy) failed to significantly prolong survival among patients with advanced prostate cancer who had previously received chemotherapy, according to limited data from the first...
By Kathryn Doyle NEW YORK (Reuters Health) – In a study of older men who died from causes other than prostate cancer, almost half were found to have prostate tumors. And up to half of those tumors detected on autopsy would have qualified for...
By Genevra Pittman NEW YORK (Reuters Health) – Men treated for prostate cancer with androgen deprivation therapy have a higher risk of developing kidney problems, a new study suggests. The treatment lowers the risk of death among men with advanced,...
12